| Name | PF-06882961 |
|---|---|
| Synonyms |
(S)-2-((4-(6-((4-Cyano-2-fluorobenzyloxy))-pyridin-2-yl)piperidin-1-yl)methyl)-1-(oxetan-2-ylmethyl)-1H-benzo[d]imidazol-6-cboxylic acid
2-[(4-{6-[(4-cyano-2-fluorophenyl)methoxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[(2S)-oxetan-2-yl]methyl}-1H-benzimidazole-6-cboxylic acid 2-[[4-[6-[(4-Cyano-2-fluorophenyl)methoxy]-2-pyridinyl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]-1H-benzimidazole-6-cboxylic acid 1H-Benzimidazole-6-cboxylic acid, 2-[[4-[6-[(4-cyano-2-fluorophenyl)methoxy]-2-pyridinyl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl] Danuglipron (PF-06882961) ,S9851 2-[[4-[6-[(4-cyano-2-fluorophenyl)methoxy]-2-pyridinyl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl PF 06882961,PF PF-06882961;PF 06882961;PF Danuglipron tris salt (S)-2-[[4-[6-[(4-Cyano-2-fluorobenzyl)oxy]-2-pyridyl]-1-piperidyl]methyl]-1-(oxetan-2-ylmethyl)-1H-benzo[d]imidazole-6-cboxylic Acid 2-[[4-[6-[(4-CYANO-2-FLUOROPHENYL)METHOXY]PYRIDIN-2-YL]PIPERIDIN-1-YL]METHYL]-3-[[(2S)-OXETAN-2-YL]M 2-[[4-[6-[(4-cyano-2-fluorophenyl)methoxy]pyridin-2-yl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazole-5-cboxylic acid PF-06882961, 10 mM in DMSO Danuglipron (PF-06882961) (S)-2-((4-(6-((4-cyano-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(oxetan-2-ylmethyl)-1H-benzo[d]imidazole-6-cboxylic acid |
| Description | PF-06882961 is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor (GLP-1R). |
|---|
| Molecular Formula | C31H30FN5O?4 |
|---|---|
| Molecular Weight | 555.60 |